Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5O7A

Quinolin-6-yloxyacetamides are microtubule destabilizing agents that bind to the colchicine site of tubulin

Summary for 5O7A
Entry DOI10.2210/pdb5o7a/pdb
DescriptorTubulin alpha-1B chain, Tubulin beta-2B chain, Stathmin-4, ... (10 entities in total)
Functional Keywordsmicrotubules, tubulin, colchicine, quinolin-6-yloxyacetamides, motor protein
Biological sourceRattus norvegicus (Norway Rat)
More
Cellular locationCytoplasm, cytoskeleton: P81947 Q6B856
Golgi apparatus : P63043
Total number of polymer chains6
Total formula weight264877.29
Authors
Sharma, A.,Olieric, N.,Steinmetz, M.O. (deposition date: 2017-06-08, release date: 2017-07-05, Last modification date: 2024-05-08)
Primary citationSharma, A.,Saez-Calvo, G.,Olieric, N.,de Asis Balaguer, F.,Barasoain, I.,Lamberth, C.,Diaz, J.F.,Steinmetz, M.O.
Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin.
Int J Mol Sci, 18:-, 2017
Cited by
PubMed Abstract: Quinolin-6-yloxyacetamides (QAs) are a chemical class of tubulin polymerization inhibitors that were initially identified as fungicides. Here, we report that QAs are potent anti-proliferative agents against human cancer cells including ones that are drug-resistant. QAs act by disrupting the microtubule cytoskeleton and by causing severe mitotic defects. We further demonstrate that QAs inhibit tubulin polymerization in vitro. The high resolution crystal structure of the tubulin-QA complex revealed that QAs bind to the colchicine site on tubulin, which is targeted by microtubule-destabilizing agents such as colchicine and nocodazole. Together, our data establish QAs as colchicine-site ligands and explain the molecular mechanism of microtubule destabilization by this class of compounds. They further extend our structural knowledge on antitubulin agents and thus should aid in the development of new strategies for the rational design of ligands against multidrug-resistant cancer cells.
PubMed: 28640209
DOI: 10.3390/ijms18071336
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.495 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon